Evidence map›Paper›PMID 33799675›Full record

ArticleBiomedicines2021

The Association between HDL-C and Subclinical Atherosclerosis Depends on CETP Plasma Concentration: Insights from the IMPROVE Study.

Gualtiero I Colombo, Vanessa Bianconi, Alice Bonomi, Sara Simonelli, Mauro Amato, Beatrice Frigerio, Alessio Ravani, Cecilia Vitali, Daniela Sansaro, Daniela Coggi and 12 more

Open access · goldAbstract read
In one paragraph

Article in Biomedicines, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 12 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 7 institutions in 6 countries.

Gualtiero I ColomboCentro Cardiologico Monzino IRCCS, 20138 Milan, Italy.ORCID 0000-0002-7348-1939
Vanessa BianconiDepartment of Medicine, University of Perugia, 06129 Perugia, Italy.
Alice BonomiCentro Cardiologico Monzino IRCCS, 20138 Milan, Italy.
Sara SimonelliDepartment of Pharmacological and Biomolecular Sciences, Università degli Studi di Milano, 20133 Milan, Italy.
Mauro AmatoCentro Cardiologico Monzino IRCCS, 20138 Milan, Italy.ORCID 0000-0002-0118-5719
Beatrice FrigerioCentro Cardiologico Monzino IRCCS, 20138 Milan, Italy.
Alessio RavaniCentro Cardiologico Monzino IRCCS, 20138 Milan, Italy.
Cecilia VitaliDepartment of Pharmacological and Biomolecular Sciences, Università degli Studi di Milano, 20133 Milan, Italy.
Daniela SansaroCentro Cardiologico Monzino IRCCS, 20138 Milan, Italy.
Daniela CoggiDepartment of Pharmacological and Biomolecular Sciences, Università degli Studi di Milano, 20133 Milan, Italy.
Massimo R MannarinoDepartment of Medicine, University of Perugia, 06129 Perugia, Italy.ORCID 0000-0003-4694-5504
Kai P SavonenFoundation for Research in Health Exercise and Nutrition, Kuopio Research Institute of Exercise Medicine, 70100 Kuopio, Finland.
Sudhir KurlInstitute of Public Health and Clinical Nutrition, University of Eastern Finland, 70210 Kuopio, Finland.
Bruna GiganteDepartment of Medicine, Karolinska Institutet, 17177 Stockholm, Sweden.
Andries J SmitDepartment of Medicine, University Medical Center Groningen, 9700 RB Groningen, The Netherlands.
Philippe GiralDepartment of Endocrinology, Metabolism, and Prevention of Cardiovascular Diseases, Hôpital Pitié-Salpêtrière-Sorbonne University, 75651 Paris, France.
Elena TremoliCentro Cardiologico Monzino IRCCS, 20138 Milan, Italy.
Laura CalabresiDepartment of Pharmacological and Biomolecular Sciences, Università degli Studi di Milano, 20133 Milan, Italy.
Fabrizio VegliaCentro Cardiologico Monzino IRCCS, 20138 Milan, Italy.ORCID 0000-0002-9378-8874
Matteo PirroDepartment of Medicine, University of Perugia, 06129 Perugia, Italy.
Damiano BaldassarreCentro Cardiologico Monzino IRCCS, 20138 Milan, Italy.ORCID 0000-0002-2766-8882
On Behalf Of The Improve Study Group
Centro Cardiologico Monzino · ITUniversity of Milan · ITUniversity of Perugia · ITKarolinska Institutet · SESorbonne Université · FRUniversity Medical Center Groningen · NLUniversity of Eastern Finland · FI

Funding

European Commission, Fifth Framework Programme QLG1- CT- 2002- 00896Ministero della Salute, Italy RC2018 MMP4.9 ID:2634520Ministero della Salute, Italy RC2019 MPP 4D ID:2755475
6 · The paper itself

Abstract

The impact of cholesteryl ester transfer protein (CETP) on atherosclerosis is highly debated. This study aimed to investigate the associations between plasma CETP or CETP genotypes and carotid intima-media thickness (cIMT) and the influence of high-density lipoprotein cholesterol (HDL-C) on these associations. Plasma CETP and HDL-C concentrations were measured in 552 subjects free of any pharmacological treatment from the IMPROVE cohort, which includes 3711 European subjects at high cardiovascular risk. CETP single-nucleotide polymorphisms (SNPs) and cIMT measures (cIMT

Indexed as

atherosclerosiscarotid intima-media thicknesscholesteryl ester transfer proteinHDL-Csingle-nucleotide polymorphisms

Identifiers

PMID33799675
PMCPMC7999018
OpenAlexW3135181493

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.